Ramaswamy Sundararajan
Overview
Explore the profile of Ramaswamy Sundararajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan N, Patel D, Sundararajan R
Am J Gastroenterol
. 2024 Oct;
120(3):667-670.
PMID: 39436267
Introduction: There is paucity of data on the incidence of severe thiopurine (TP)-induced myelosuppression (TIM) among patients with inflammatory bowel disease (IBD). Methods: Using the Veterans Affairs Healthcare System, we...
2.
Sundararajan R, Patel M, Bahirwani J, Trivedi C, Mahmud N, Khan N
Crohns Colitis 360
. 2024 Aug;
6(3):otae046.
PMID: 39188766
Background: There is limited data on the long-term clinical outcomes of bio-naïve ulcerative colitis (UC) patients who are initiated on adalimumab (ADA). Our study aims to evaluate the clinical course...
3.
Khan N, Sundararajan R, Patel M, Trivedi C, Yang Y
Am J Gastroenterol
. 2024 Mar;
PMID: 38483302
Introduction: There is paucity of data on the effectiveness and safety of tofacitinib among elderly patients with ulcerative colitis (UC). Methods: Through a retrospective cohort study among the US National...
4.
Soni A, Yekula A, Dahiya D, Sundararajan R, Dutta P, Singh Y, et al.
Ann Gastroenterol
. 2023 Nov;
36(6):646-653.
PMID: 38023970
Background: The reported prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) is 32%. We assessed the influence of NAFLD on IBD hospitalizations in the...
5.
Parikh C, Upadhyay H, Patel S, Sundararajan R, Shah D, Anand A, et al.
J Nephrol
. 2023 Jul;
36(9):2431-2440.
PMID: 37505405
Background: Severe acute respiratory syndrome coronavirus 2 infection has caused significant morbidity and mortality. Vaccines produced against this virus have proven highly effective. However, adverse events following vaccination have also...
6.
Khan N, Trivedi C, Shah Y, Patel M, Sundararajan R, Xie D, et al.
J Clin Gastroenterol
. 2023 May;
58(3):277-280.
PMID: 37252728
Background And Goals: Community Acquired Pneumonia (CAP) is among the most common infections among Inflammatory Bowel Disease (IBD) patients. Our aim was to determine the absolute and relative risk of...
7.
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W
Aliment Pharmacol Ther
. 2023 Jan;
57(7):800-807.
PMID: 36645110
Background: The Inflammatory Bowel Disease (IBD) patients have adopted lifestyle modifications to prevent infection via SARS COV-2. Aims: This study aims to examine rate of serious infections and opportunistic infections...
8.
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W
Clin Gastroenterol Hepatol
. 2022 Dec;
21(7):1960-1962.e1.
PMID: 36566815
No abstract available.
9.
Mahmud N, Reinisch W, Patel M, Sundararajan R, Khan N
Clin Transl Gastroenterol
. 2022 Dec;
14(4):e00554.
PMID: 36508224
Introduction: There are limited data on the safety profile of the severe acute respiratory syndrome coronavirus-2 vaccine among patients taking immunosuppressive medications. Our aim was to evaluate the adverse events...
10.
Benitez J, Hernandez T, Sundararajan R, Sarwar S, Arriaga A, Khan A, et al.
Cureus
. 2022 Oct;
14(9):e29468.
PMID: 36299970
Background And Objectives: St. John's wort (SJW) extracts are currently being used to treat depression of various degrees of severity. While many studies have shown it to be superior to...